Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Drug Metabolism And Disposition

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/DMD.32.7.734PMID 15205389
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis

  2003cited by this paper
• Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle.

  2003cited by this paper
• The presence of xenobiotic transporters in rat placenta.

  2003influential reference
• Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice.

  2002cited by this paper
• Tissue expression, ontogeny, and inducibility of rat organic anion transporting polypeptide 4.

  2002influential reference
• Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats.

  2002cited by this paper
• Gender-specific and developmental influences on the expression of rat organic anion transporters.

  2002cited by this paper
• Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in Endotoxemia

  2002cited by this paper
• Messenger RNA profiles in liver injury and stress: a comparison of lethal and nonlethal rat models.

  2002cited by this paper
• Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels.

  2002influential reference
• Tissue distribution and chemical induction of multiple drug resistance genes in rats.

  2002influential reference
• Heat stress prevents impairment of bile acid transport in endotoxemic rats by a posttranscriptional mechanism.

  2002cited by this paper
• Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice.

  2001cited by this paper
• Protective effect of melatonin against oxidative stress induced by ligature of extra‐hepatic biliary duct in rats: comparison with the effect of S‐adenosyl‐l‐methionine

  2000cited by this paper
• Foreword: from classic bile physiology to cloned transporters.

  2000cited by this paper
• Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats.

  2000cited by this paper
• Hepatic Transport of Bile Salts

  2000cited by this paper
• Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver Disorders

  2000cited by this paper
• Melatonin protects against stress‐induced gastric lesions by scavenging the hydroxyl radical

  2000cited by this paper
• Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression.

  1999influential reference
• Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)*

  1999cited by this paper
• Effects of LPS on transport of indocyanine green and alanine uptake in perfused rat liver.

  1999cited by this paper
• Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1.

  1999cited by this paper
• Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone.

  1999influential reference
• Voltage-dependent outward K+current in intermediate cell of stria vascularis of gerbil cochlea.

  1999cited by this paper
• Up‐regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down‐regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver

  1998cited by this paper
• Cytokines and the hepatic acute phase response

  1997cited by this paper
• The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis.

  1997cited by this paper
• Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents.

  1996influential reference
• Participation of hepatic macrophages and plasma factors in endotoxin-induced liver injury.

  1995cited by this paper
• Tumor necrosis factor–alpha decreases hepatocyte bile salt uptake and mediates endotoxin‐induced cholestasis

  1995influential reference
• Impaired hepatocanalicular organic anion transport in endotoxemic rats.

  1995influential reference
• Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses.

  1994cited by this paper
• Characterization of cloned rat liver Na(+)-bile acid cotransporter using peptide and fusion protein antibodies.

  1994cited by this paper
• Heterogeneity of rat liver and spleen macrophages in gadolinium chloride–induced elimination and repopulation

  1992cited by this paper
• Preserved cytosolic and synthetic liver function in jaundice of severe extrahepatic infection.

  1989cited by this paper
• Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone.

  1987cited by this paper
• Reduction of Serum Interleukin‐1‐Like Activity After Treatment With Dexamethasone

  1985cited by this paper
• Goodman & Gilman's The Pharmacological Basis of Therapeutics

  1985cited by this paper
• Studies on the effects of C. coli endotoxin on canalicular bile formation in the isolated perfused rat liver.

  1977cited by this paper

• Interleukin 1 β suppresses bile acid-induced BSEP expression via a CXCR2-dependent feedback mechanism

  2024cites this paper
• Mechanisms of lipopolysaccharide protection in tumor drug-induced macrophage damage.

  2024cites this paper
• Using simulations to explore the potential effect of disease and inflammation on the frequency of violative flunixin residues in cattle.

  2023cites this paper
• Inflammation affects the pharmacokinetics of risperidone: Does the dose need to be adjusted during the acute-phase reaction?

  2023cites this paper
• Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs

  2022cites this paper
• The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action

  2022cites this paper
• Idiosyncratic liver injury induced by bolus combination treatment with emodin and 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucopyranoside in rats

  2022cites this paper
• Pharmacokinetic Imaging Using 99mTc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats

  2022cites this paper
• Piecing together human adult comparative pharmacokinetic trials and rodent studies: What happens to drug clearance in obesity?

  2022cites this paper
• Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology

  2022cites this paper
• Drug-Drug Interactions at Organic Cation Transporter 1

  2021cites this paper
• Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition

  2021cites this paper
• Chorioamnionitis induces hepatic inflammation and time-dependent changes of the enterohepatic circulation in the ovine fetus

  2021cites this paper
• Dysregulation of renal transporters in a rodent model of viral Infection.

  2020cites this paper
• Spironolactone ameliorates lipopolysaccharide-induced cholestasis in rats by improving Mrp2 function: Role of transcriptional and post-transcriptional mechanisms.

  2020cites this paper
• Increased penetration of diphenhydramine in brain via proton-coupled organic cation antiporter in rats with lipopolysaccharide-induced inflammation

  2020cites this paper
• The Specific Bile Acid Profile of Shock: A Hypothesis Generating Appraisal of the Literature

  2020cites this paper
• Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics.

  2019cites this paper
• Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.

  2019cites this paper
• Effect of early and delay starting of enteral feeding in post-pancreaticoduodenectomy patients

  2019cites this paper
• Effects of inflammation on irinotecan pharmacokinetics and development of a best-fit PK model.

  2019cites this paper
• The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders

  2018cites this paper
• P-glycoprotein and chronic rhinosinusitis

  2018cites this paper
• Dexamethasone restores transforming growth factor‐&bgr; activated kinase 1 expression and phagocytosis activity of Kupffer cells in cholestatic liver injury

  2018cites this paper
• Glucocorticoids alleviates lipopolysaccharide-induced acute liver injury associated with promoting the expression of NTCP and BSEP

  2017cites this paper
• PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE: THE EFFECTS OF ALUMINUM CONTAMINATION AND LIPID COMPOSITION ON BILE ACID TRANSPORTERS

  2017cites this paper
• Bilirubin modulates leukocyte recruitment to sites of inflammation

  2017cites this paper
• Regulation of Drug Transporters by Inflammation

  2017cites this paper
• Acute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome

  2017cites this paper
• Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide

  2017cites this paper
• Stereoselective hepatic disposition of ibuprofen in the perfused liver of rat with adjuvant-induced arthritis

  2017cites this paper
• On the Role of Illness Duration and Nutrient Restriction in Cholestatic Alterations that Occur During Critical Illness

  2017cites this paper
• Cholestatic Alterations in the Critically Ill: Some New Light on an Old Problem

  2017cites this paper
• Running title: Impact of endotoxin on drug transporters in HIV-Tg rats

  2017cites this paper
• Physiological and Pathophysiological Regulation of Transporters for Organic Cations

  2016cites this paper
• Hepatic and Intestinal Multidrug Resistance-Associated Protein 2: Transcriptional and Post-transcriptional Regulation by Xenobiotics

  2016cites this paper
• Endotoxin-Mediated Downregulation of Hepatic Drug Transporters in HIV-1 Transgenic Rats

  2016influential citation
• Altered Expression of Transporters, its Potential Mechanisms and Influences in the Liver of Rodent Models Associated with Diabetes Mellitus and Obesity

  2016cites this paper
• Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation

  2016cites this paper
• Comparative study of CYP2B1/2 induction and the transport of bilirubin and taurocholate in rat hepatocyte-mono- and hepatocyte-Kupffer cell co-cultures.

  2016cites this paper
• Influence of P-Glycoprotein Function on Chronic Rhinosinusitis/Nasal Polyps Pathophysiology.

  2016cites this paper
• Effect of Disease Pathologies on Transporter Expression and Function

  2016cites this paper
• Organic Cation Transporters

  2016cites this paper
• Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation

  2016cites this paper
• Cholestatic liver (dys)function during sepsis and other critical illnesses

  2015cites this paper
• Infection-mediated Modulation of Drug Transporters in Pregnancy; Implications for Fetal Drug Exposure

  2015cites this paper
• Decreased liver distribution of entecavir is related to down-regulation of Oat2/Oct1 and up-regulation of Mrp1/2/3/5 in rat liver fibrosis.

  2015cites this paper
• IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats.

  2015cites this paper
• Laparoscopic Radiofrequency Ablation Should Be Considered a Safe Treatment for Hepatocellular Carcinoma Patients with Severe Cirrhosis and Impaired ICG-15 Test

  2015cites this paper
• Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr−/− mouse model

  2015cites this paper
• Expression of ATP-binding cassette membrane transporters in a HIV-1 transgenic rat model.

  2014cites this paper
• Stress in the liver: stereotypic genomic responses in vitro and in vivo involve inflammation and loss of metabolic functions

  2014cites this paper
• E. coli Infection Modulates the Pharmacokinetics of Oral Enrofloxacin by Targeting P-Glycoprotein in Small Intestine and CYP450 3A in Liver and Kidney of Broilers

  2014cites this paper
• Potential pharmacokinetic interactions of therapeutic cytokines or cytokine modulators on small-molecule drugs: mechanistic understanding via studies using in vitro systems

  2014cites this paper
• The role of vitamin A in bile acid synthesis and transport and the relevance for cholestatic liver disease

  2013cites this paper
• Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters

  2013cites this paper
• Hepatic changes in systemic infection.

  2013cites this paper
• The hepatic bile acid transporters Ntcp and Mrp2 are downregulated in experimental necrotizing enterocolitis.

  2013cites this paper
• Characterization of System xc -, a Cystine-Glutamate Amino Acid Transporter, as an Effector of Interleukin-1β-Mediated Injury and Neuroprotection

  2013cites this paper
• Estrogen receptor-α mediates human multidrug resistance associated protein 3 induction by 17α-ethynylestradiol. Role of activator protein-1.

  2013cites this paper
• Potential Factors Dedicated to Postoperative Liver Dysfunction in Patients with Normal Preoperative ICG-15 Clearance Rate

  2013cites this paper
• Best Practice & Research Clinical Gastroenterology

  2013cites this paper
• The molecular pathogenesis of cholestasis in sepsis.

  2013cites this paper
• Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury.

  2013influential citation
• The Mechanism of the Down-Regulation of Hepatic Transporters in Rats with Indomethacin-Induced Intestinal Injury

  2013cites this paper
• Inflammatory Mediators Increase SUMOylation of Retinoid X Receptor α in a c-Jun N-Terminal Kinase–Dependent Manner in Human Hepatocellular Carcinoma Cells

  2013cites this paper
• Cross-Talk Between Neurons and Astrocytes in Response to Bilirubin: Adverse Secondary Impacts

  2013cites this paper
• Differential Regulation of Hepatic Organic Cation Transporter 1, Organic Anion-Transporting Polypeptide 1a4, Bile-Salt Export Pump, and Multidrug Resistance-Associated Protein 2 Transporter Expression in Lymphocyte-Deficient Mice Associates with Interleukin-6 Production

  2013cites this paper
• Effect of inflammation on molecular targets and drug transporters.

  2012cites this paper
• Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response

  2012cites this paper
• Les répercussions de l’insuffisance rénale chronique sur le transport des médicaments

  2012cites this paper
• Enhanced renal clearance of vancomycin in rats with carcinogen-induced osteosarcoma.

  2012cites this paper
• Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis

  2012cites this paper
• Drug disposition in pathophysiological conditions.

  2012cites this paper
• Regulation of Drug Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

  2012cites this paper
• Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions

  2012cites this paper
• Solute Carrier (SLC) Family Transporters

  2012cites this paper
• Effect of NAFLD on Regulation of Hepatic Transporters and Metaboic Enzymes Using a High Fat/ High Cholesterol Dietary Model in Rats

  2012cites this paper
• Impact of Diabetes on Drug Disposition Mechanisms in Pregnancy

  2012cites this paper
• The effects of gastric bypass surgery on drug absorption and pharmacokinetics

  2012cites this paper
• Modulation in concentrative nucleoside transporters-mediated intestinal absorption of mizoribine, an immunosuppressive agent, in lipopolysaccharide-treated rats.

  2011cites this paper
• Effect of adjuvant-induced systemic inflammation in rats on hepatic disposition kinetics of taurocholate.

  2011cites this paper
• [A review on regulation of drug transporters during inflammation].

  2011cites this paper
• TREPROSTINIL FOR PROTECTION OF LIVER GRAFTS AGAINST ISCHEMIA AND REPERFUSION INJURY DURING ORTHOTOPIC LIVER TRANSPLANTATION - A TRANSLATIONAL STUDY

  2011cites this paper
• Organic anion transporting polypeptides (OATPs): regulation of expression and function.

  2011cites this paper
• In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.

  2011cites this paper
• Drug-Cytokine Interactions

  2011cites this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Critical Illness Evokes Elevated Circulating Bile Acids Related to Altered Hepatic Transporter and Nuclear Receptor Expression

  2011cites this paper
• Impact of Polyinosinic/Polycytidylic Acid on Placental and Hepatobiliary Drug Transporters in Pregnant Rats

  2010cites this paper
• Drug Transporter Expression and Localization in Rat Nasal Respiratory and Olfactory Mucosa and Olfactory Bulb

  2010cites this paper
• Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

  2010influential citation
• Effects of lipopolysaccharide on P-glycoprotein expression and activity in the liver and kidneys.

  2010cites this paper
• Oxidative stress is a triggering factor for LPS-induced Mrp2 internalization in the cryopreserved rat and human liver slices.

  2010cites this paper
• Regulation of Multidrug Resistance Protein 1 by Tumor Necrosis Factor α in Cultured Glial Cells: Involvement of Nuclear Factor-κB and c-Jun N-Terminal Kinase Signaling Pathways

  2010cites this paper
• Functional Implications of Transporters Under Nitrosative Stress Conditions

  2010cites this paper
• Regulation of Hepatobiliary Transporters during Liver Injury

  2010cites this paper
• The effect of dimerumic acid on LPS-induced downregulation of Mrp2 in the rat.

  2010cites this paper
• The Role of Inflammation in Cholestasis: Clinical and Basic Aspects

  2010cites this paper
• Regulation of hepatic ABCC transporters by xenobiotics and in disease states

  2010influential citation
• Regulation of Multidrug Resistance Protein 1 by Tumor Necrosis Factor (cid:1) in Cultured Glial Cells: Involvement of Nuclear Factor- (cid:2) B and c-Jun N-Terminal Kinase Signaling Pathways

  2010cites this paper